These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3488045)

  • 1. Erythromycin-oral anticoagulants interaction.
    Grau E; Fontcuberta J; Félez J
    Arch Intern Med; 1986 Aug; 146(8):1639. PubMed ID: 3488045
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatotoxicity of erythromycin ethylsuccinate in a child.
    Phillips KG
    Can Med Assoc J; 1983 Sep; 129(5):411-2. PubMed ID: 6603894
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatitis due to erythromycin ethylsuccinate].
    Funck-Brentano C; Danan G; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1982 Dec; 6(12):1044-5. PubMed ID: 6984402
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged cholestasis and disappearance of interlobular bile ducts following chlorpropamide and erythromycin ethylsuccinate. Case of drug interaction?
    Geubel AP; Nakad A; Rahier J; Dive C
    Liver; 1988 Dec; 8(6):350-3. PubMed ID: 3265170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics and tolerance of oral erythromycin stearate compared with erythromycin ethylsuccinate: implications for preventing endocarditis.
    Shanson DC; Tidbury P; McNabb WR; Tadayon M
    J Antimicrob Chemother; 1984 Aug; 14(2):157-63. PubMed ID: 6334070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythromycin ethylsuccinate-induced cholestasis.
    Bachman BA; Boyd WP; Brady PG
    Am J Gastroenterol; 1982 Jun; 77(6):397-400. PubMed ID: 6979924
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute hepatitis caused by erythromycin esters (propionate and ethylsuccinate)].
    Paliard P; Stremsdoerfer N; Moindrot H
    Gastroenterol Clin Biol; 1983 Jan; 7(1):100-1. PubMed ID: 6601598
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatotoxicity of erythromycin].
    García Buey L; García-Samaniego Rey J; González Estecha A; Pajares García JM
    Rev Clin Esp; 1989 Feb; 184(3):158. PubMed ID: 2785700
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythromycin ethylsuccinate hepatotoxicity.
    Sullivan D; Csuka ME; Blanchard B
    JAMA; 1980 Mar; 243(10):1074. PubMed ID: 6965509
    [No Abstract]   [Full Text] [Related]  

  • 10. Rosuvastatin-acenocoumarol interaction.
    Mondillo S; Ballo P; Galderisi M
    Clin Ther; 2005 Jun; 27(6):782-4. PubMed ID: 16117985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypothermia associated with erythromycin].
    Cárdenes M; Artiles J; Arkuch A; Suárez S
    Med Clin (Barc); 1992 May; 98(18):715-6. PubMed ID: 1602886
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythromycin ethylsuccinate, base and acistrate in the treatment of upper respiratory tract infection: two comparative studies of tolerability.
    Saloranta P; Roos L; Elonen E; Allonen H
    J Antimicrob Chemother; 1989 Sep; 24(3):455-62. PubMed ID: 2808197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between cyclosporine and acenocoumarol in a patient with nephrotic syndrome.
    Borrás-Blasco J; Enriquez R; Navarro-Ruiz A; Martinez-Ramirez M; Cabezuelo JB; Gonzalez-Delgado M
    Clin Nephrol; 2001 Apr; 55(4):338-40. PubMed ID: 11334326
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatotoxic reaction to erythromycin ethylsuccinate.
    Patel J; Schneider R
    South Med J; 1984 Oct; 77(10):1343-4. PubMed ID: 6333077
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in erythromycin pharmacokinetics induced by renal failure.
    Kanfer A; Stamatakis G; Torlotin JC; Fredj G; Kenouch S; Méry JP
    Clin Nephrol; 1987 Mar; 27(3):147-50. PubMed ID: 3494560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin interaction with erythromycin.
    Sato RI; Gray DR; Brown SE
    Arch Intern Med; 1984 Dec; 144(12):2413-4. PubMed ID: 6508448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of erythromycin ethyl-succinate in oral surgery. Apropos of 30 cases].
    Feki A
    Inf Dent; 1982 Feb; 64(5):369-72. PubMed ID: 6978850
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatotoxic syndrome caused by erythromycin ethyl succinate].
    Cocchi P; Silenzi M; Salvi G; Calabri G; Tamburini M; Alvisi P
    Minerva Pediatr; 1982 Jan; 34(1-2):68-9. PubMed ID: 6978458
    [No Abstract]   [Full Text] [Related]  

  • 19. [Erythrocin].
    Csech J; Gervais C
    Soins Chir; 1982 Dec; (22):47-8. PubMed ID: 6984785
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythromycin ethylsuccinate-induced cholestasis.
    Viteri AL; Greene JF; Dyck WP
    Gastroenterology; 1979 May; 76(5 Pt 1):1007-8. PubMed ID: 437404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.